Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 62949Erstellt: 3. November 2026

Cimetidine sulfoxide

SKF-92452 · Cimetidine S-oxide · cimetidine sulfoxide · Cimetidine impurity E · Cimetidine sulphoxide · Cimetidine EP Impurity E · (+/-)-Cimetidine S-oxide · Cimetidine Impurity E(EP)

https://huagongshe.com/de/chemical/62949

Molekülstruktur von Cimetidine sulfoxide

Identifikatoren & physikalische Daten

CAS No.151258-41-2
SummenformelC10H16N6OS
Durchschnittliche Molmasse268,34 g/mol
Monoisotopische Masse268,11063033 g/mol
SMILESCN=C(NC#N)NCCS(=O)Cc1nc[nH]c1C
InChIKeyHOJLJLYVNQFCRE-UHFFFAOYSA-N
PubChem CID62949
ChEMBLCHEMBL3544520
ChEBICHEBI:30731
EC No.641-511-4
DTXSIDDTXSID50969219

Chemische & physikalische Eigenschaften

XLogP-1,1
Polarare Oberfläche (TPSA)125
H-Brücken-Donoren3
H-Brücken-Akzeptoren5
Frei drehbare Bindungen7
Schwere Atome18
Formalladung0
Komplexität363
Schmelzpunkt>180°C (dec.)
Siedepunkt594.8±60.0 °C(Predicted)
Dichte1.39±0.1 g/cm3(Predicted)
Lagerbedingungen-20°C Freezer
LöslichkeitDMSO (Slightly, Heated), Methanol (Slightly)
AggregatzustandSolid
pKa (Säurekonstante)13.38±0.10(Predicted)
FarbeWhite to Off-White
Hauptanwendungenpharmaceutical
InChI1S/C10H16N6OS/c1-8-9(16-7-15-8)5-18(17)4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)
InChIKeyHOJLJLYVNQFCRE-UHFFFAOYSA-N
SMILES[S](=O)(CCN\C(=N/C)\NC#N)Cc1nc[nH]c1C

Sicherheit & Vorschriften

GHS-EinstufungDangerH351 (50%): Suspected of causing cancer [Warning Carcinogenicity]P203, P280, P318, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard Classes and CategoriesCarc. 2 (50%)
Wassergefährdungsklasse (WGK)WGK 3
Lagerklasse11 - Combustible Solids

Anwendungen & Verwendung

Verwenden

Cimetidine Sulfoxide is a metabolite of the H2-receptor antagonist Cimetidine (C441650). Cimetidine Sulfoxide is detected in the blood and urine of patients with kidney diseases.